Parenteral Drugs (India) reports consolidated net loss of Rs 21.03 crore in the March 2015 quarter

Sales rise 5.18% to Rs 61.76 crore

Net Loss of Parenteral Drugs (India) reported to Rs 21.03 crore in the quarter ended March 2015 as against net loss of Rs 62.46 crore during the previous quarter ended March 2014. Sales rose 5.18% to Rs 61.76 crore in the quarter ended March 2015 as against Rs 58.72 crore during the previous quarter ended March 2014.

For the full year,net loss reported to Rs 67.63 crore in the year ended March 2015 as against net loss of Rs 45.17 crore during the previous year ended March 2014. Sales declined 4.03% to Rs 262.67 crore in the year ended March 2015 as against Rs 273.70 crore during the previous year ended March 2014.

ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales61.7658.72 5 262.67273.70 -4 OPM %8.05-59.49 -5.82-8.17 - PBDT-14.01-49.91 72 -54.97-82.58 33 PBT-27.75-54.86 49 -85.95-101.20 15 NP-21.03-62.46 66 -67.63-45.17 -50

Powered by Capital Market - Live News